Milestone Scientific (MLSS) Common Equity (2010 - 2026)

Milestone Scientific has disclosed Common Equity across 17 years of filings, most recently posting $2.3 million for Q1 2026.

• In Q1 2026, Common Equity fell 48.8% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (down 48.8% YoY), while the FY2025 annual figure was $125.0 million, up 2043.09% from the prior year.
• Common Equity came in at $2.3 million for Q1 2026 at Milestone Scientific, down from $125.0 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $125.0 million in Q4 2025 to a low of $2.3 million in Q1 2026.
• Average Common Equity over 5 years is $14.5 million, with a median of $7.7 million recorded in 2023.
• The largest YoY upside for Common Equity was 2043.09% in 2025 against a maximum downside of 64.7% in 2025.
• Over 5 years, Common Equity stood at $10.0 million in 2022, then dropped by 19.93% to $8.0 million in 2023, then declined by 27.21% to $5.8 million in 2024, then soared by 2043.09% to $125.0 million in 2025, then tumbled by 98.17% to $2.3 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $2.3 million in Q1 2026, $125.0 million in Q4 2025, and $2.5 million in Q3 2025.